VIP and inflammatory bowel disease: On the contrary, the more standardized studies on IBD-like animal models have shown a constant increase in SP and a decrease in VIP expression during the active phases of the diseases (O’Connor et al., 2004; Gonzalez-Rey et al., 2006; Margolis and Gershon, 2009; El-Salhy et al., 2017).